Zenotech Challenges India's FIPB Over Daiichi Sankyo Share Acquisition
This article was originally published in PharmAsia News
Executive Summary
India's Foreign Investment Promotion Board is being challenged for granting Daiichi Sankyo permission to buy a 20% share of Zenotech Laboratories.